Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)

Peer Review reports

Original Submission
11 Mar 2021	Submitted	Original manuscript
12 Apr 2021	Reviewed	Reviewer Report - Riaz Qureshi
19 May 2021	Author responded	Author comments - Barbara Soria-Juan
Resubmission - Version 2
19 May 2021	Submitted	Manuscript version 2
30 May 2021	Reviewed	Reviewer Report - Riaz Qureshi
28 Jun 2021	Author responded	Author comments - Barbara Soria-Juan
Resubmission - Version 3
28 Jun 2021	Submitted	Manuscript version 3
Publishing
7 Jul 2021	Editorially accepted
6 Sep 2021	Article published	10.1186/s13063-021-05430-2

Back to article page